News
Posted
All
| 2020 | 2019 | 2018 | 2017
RESEARCH UPDATE: ON THE CLINICAL FRONT Zinc Induces Potential Chemopreventive Activity in Barrett’s Esophagus Zinc’s chemopreventive activity for esophageal cancer has been well demonstrated in animal models. In humans,... Read More
POSTED: 07/30/2020
SOURCE: DCP News
Responding to Coronavirus, Cancer Researchers Reimagine Clinical Trials
When the coronavirus pandemic reached the United States, thousands of people with cancer were participating in clinical trials, including many at St. Jude Children’s Research Hospital in Memphis, Tennessee. At St. Jude,... Read More
POSTED: 06/29/2020
SOURCE: NCI Cancer Currents Blog
NIH scientists develop blood test to help improve liver cancer screening
Scientists have developed a new test that can help identify people who are likely to develop hepatocellular carcinoma (HCC), the most common form of liver cancer. The approach uses a simple blood test to check for the... Read More
POSTED: 06/11/2020
SOURCE: NCI Press Release
A new technology coupled with a new biomarker test now in clinical trials are giving patients timely access to a quick, accurate and less invasive way to identify risk for one type of esophageal cancer. EsoCheck™ and... Read More
POSTED: 06/01/2020
SOURCE: Cancer Prevention Science Blog
How Does COVID-19 Affect People with Cancer? NCCAPS Will Help Find Out
With the sudden explosion of the COVID-19 pandemic, we are all living with a great deal of fear, uncertainty, and anxiety. As an oncologist and cancer researcher, I know that those feelings are heightened for many people... Read More
POSTED: 05/21/2020
SOURCE: NCI Cancer Currents Blog
Cancer Prevention Fellows and CPFP Staff attending the 2019 Fellows' Scientific Symposium. The annual symposium is held each fall and provides for a day of scientific exchange in the area of cancer prevention, offering the... Read More
POSTED: 05/07/2020
SOURCE: DCP News
COVID-19 is an emerging, rapidly evolving situation. In addition to the information sources listed in the web header, the National Cancer Institute and the Division of Cancer Prevention have issued guidance for DCP... Read More
POSTED: 05/07/2020
SOURCE: DCP News
NCORP Partners in ACTIV Response to COVID-19
The National Institutes of Health and the Foundation for the NIH (FNIH) are bringing together more than a dozen leading biopharmaceutical companies, the Health and Human Services Office of the Assistant Secretary for... Read More
POSTED: 05/04/2020
SOURCE: NIH Press Release
Updated: July 9, 2020 NCI participated in the American Association for Cancer Research (AACR) Annual Meetings, held virtually on April 27 - 28, 2020 (Meeting I) and June 22 - 24, 2020 (Meeting II), including presenting the... Read More
POSTED: 04/29/2020
SOURCE: DCP News
RESEARCH UPDATE: ON THE CLINICAL FRONT No Association Between Vitamin D Supplementation and Risk of Colorectal Adenomas or Polyps Vitamin D has been associated with lower incidence and mortality of colorectal cancer, yet... Read More
POSTED: 04/23/2020
SOURCE: DCP News
Single Dose of HPV Vaccine Yields Long-Term Protection from Many Cancer-Causing Types
More than a decade after vaccination, women who had received a single dose of human papillomavirus (HPV) vaccine continued to be protected against cervical infection with the two cancer-causing HPV types targeted by the... Read More
POSTED: 04/10/2020
SOURCE: NCI Cancer Currents Blog
Women Experience More Side Effects from Pelvic Radiation than Realized
Women undergoing radiation therapy for cervical or uterine cancer have a much higher incidence of serious side effects than previously realized, according to results from a new clinical trial. This information may help women... Read More
POSTED: 04/08/2020
SOURCE: NCI Cancer Currents Blog
Experimental Drug Prevents Doxorubicin from Harming the Heart
The chemotherapy drug doxorubicin is used to treat many types of cancer, but some patients who receive the drug develop heart problems. Using new insights into how doxorubicin damages the heart, researchers have identified... Read More
POSTED: 04/06/2020
SOURCE: NCI Cancer Currents Blog
While researchers have identified some of the genetic changes that lead to cancer development, a key knowledge gap remains: finding the genetic changes that drive the development of cancers that arise at an earlier age than... Read More
POSTED: 03/05/2020
SOURCE: Cancer Prevention Science Blog
RESEARCH UPDATE: ON THE CLINICAL FRONT Genetic Variants May Partially Explain Response to Tomato Juice Intake in Men with Prostate Cancer Tomato product and lycopene intakes are associated with reduced prostate cancer risk... Read More
POSTED: 02/19/2020
SOURCE: DCP News
Cervical cancer is highly preventable, yet it is not fully prevented. Significant advancements in our understanding of the human papillomavirus (HPV)-linked development of cervical cancer have created highly effective... Read More
POSTED: 02/03/2020
SOURCE: Cancer Prevention Science Blog
In the path toward understanding the development and ultimate prevention of prostate cancer, researchers are studying how to keep low-grade, early stage prostate cancer being monitored on Active Surveillance from progressing... Read More
POSTED: 01/17/2020
SOURCE: Cancer Prevention Science Blog
Division of Cancer Prevention New Grantees with Acting DCP Division Director Dr. Debbie Winn (first row center). In November 2019, the NCI Division of Cancer Prevention (DCP) for the first time held a New Grantee Workshop... Read More
POSTED: 01/14/2020
SOURCE: DCP News
As cancer researchers delve into the many molecular processes that guide cell life within the body, NCI is looking for ways to characterize and measure different substances in this process, with an eye to identifying who has... Read More
POSTED: 12/11/2019
SOURCE: Cancer Prevention Science Blog
The National Cancer Institute (NCI) is leading a project to create a cohort of people who are newly diagnosed with diabetes in the hopes that this group, who are at increased risk of developing pancreatic cancer, provide the... Read More
POSTED: 11/19/2019
SOURCE: Cancer Prevention Science Blog
Cancer Prevention Science editors spoke with Deborah Winn, Ph.D., acting director of the NCI Division of Cancer Prevention, about cancer prevention and early detection research in the division and beyond. Why is cancer... Read More
POSTED: 10/31/2019
SOURCE: Cancer Prevention Science Blog
RESEARCH UPDATE: ON THE CLINICAL FRONT Selectively Inhibitory Effects of Green Tea Polyphenols on Microbial Metabolism The bioavailability of green tea polyphenols (GTP) is limited and unabsorbed GTP can have bi-... Read More
POSTED: 10/23/2019
SOURCE: DCP News
TMIST (Tomosynthesis Mammographic Imaging Screening Trial), the large NCI screening study to learn about the best ways to find breast cancer in women who have no symptoms, is ramping up with 16,505 participants enrolled to... Read More
POSTED: 10/16/2019
SOURCE: Cancer Prevention Science Blog
Study Quantifies Impact of NCI-sponsored Trials on Clinical Cancer Care
A new study shows that nearly half of phase 3 cancer clinical trials carried out by the National Cancer Institute (NCI)-sponsored SWOG Cancer Research Network, one of five groups in NCI’s National Clinical Trials Network (... Read More
POSTED: 09/18/2019
SOURCE: NCI Press Release
Michigan’s Philip Stella receives NCORP 2019 Harry Hynes Award: Conversation with the Cancer Letter
Philip J. Stella, the principal investigator of the Michigan Cancer Research Consortium NCI Community Oncology Research Program site in Ann Arbor, won the 2019 Harry Hynes Award. The award is given annually to NCORP PIs... Read More
POSTED: 09/13/2019
SOURCE: The Cancer Letter